Fresenius Kabi

DIMENHYDRINATE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Fresenius Kabi

Dimenhydrinate HCPCS:

J1240

HCPCS Code Descriptor:

Injection, dimenhydrinate, up to 50 mg

Category:

J Code

Dimenhydrinate NDCs:

63323-0366-01

Primary Type:

Antihistamine

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Injection

Dimenhydrinate CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

63323-0366-01

About Dimenhydrinate:

DIMENHYDRINATE is an Antihistamine drug manufactured by Fresenius Kabi and administered via the Injection route of administration. The J Code: J1240 is aligned to the drug DIMENHYDRINATE.

ACCESS PRICING AND MORE BY REGISTERING

J1240 Added Date:

January 1, 1984

J1240 Effective Date:

January 1, 1997

J1240 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dimenhydrinate billing and coding information.
Our team did not identify a source for Dimenhydrinate patient assistance information. Please reach out to our team if you feel that this is a mistake.
DIMENHYDRINATE prescribing information can be found at the link below:
Information regarding DIMENHYDRINATE’s side effects can be found at MedlinePlus